JP2005505602A5 - - Google Patents

Download PDF

Info

Publication number
JP2005505602A5
JP2005505602A5 JP2003535751A JP2003535751A JP2005505602A5 JP 2005505602 A5 JP2005505602 A5 JP 2005505602A5 JP 2003535751 A JP2003535751 A JP 2003535751A JP 2003535751 A JP2003535751 A JP 2003535751A JP 2005505602 A5 JP2005505602 A5 JP 2005505602A5
Authority
JP
Japan
Prior art keywords
active agent
liposome
producing
release
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003535751A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005505602A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2002/000745 external-priority patent/WO2003032947A2/en
Publication of JP2005505602A publication Critical patent/JP2005505602A/ja
Publication of JP2005505602A5 publication Critical patent/JP2005505602A5/ja
Pending legal-status Critical Current

Links

JP2003535751A 2001-09-06 2002-09-09 予め規定された放出プロファイルを有するリポソーム調剤の製造方法 Pending JP2005505602A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31718701P 2001-09-06 2001-09-06
PCT/IL2002/000745 WO2003032947A2 (en) 2001-09-06 2002-09-09 A method for preparing liposome formulations with a predefined release profile

Publications (2)

Publication Number Publication Date
JP2005505602A JP2005505602A (ja) 2005-02-24
JP2005505602A5 true JP2005505602A5 (https=) 2006-01-05

Family

ID=23232510

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003535751A Pending JP2005505602A (ja) 2001-09-06 2002-09-09 予め規定された放出プロファイルを有するリポソーム調剤の製造方法

Country Status (7)

Country Link
US (2) US20060165766A1 (https=)
EP (1) EP1429726A2 (https=)
JP (1) JP2005505602A (https=)
AU (1) AU2002334358B2 (https=)
CA (1) CA2460209A1 (https=)
IL (1) IL160350A0 (https=)
WO (1) WO2003032947A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004233873B2 (en) 2003-04-25 2010-11-18 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
US20050129753A1 (en) * 2003-11-14 2005-06-16 Gabizon Alberto A. Method for drug loading in liposomes
WO2006027787A1 (en) * 2004-09-09 2006-03-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal compositions of glucocorticoid and glucocorticoid derivatives
JP2008512444A (ja) * 2004-09-09 2008-04-24 イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム 神経変性状態の治療のための、両親媒性弱塩基様テンパミンを含むリポソーム製剤
EP1802277B1 (de) 2004-10-18 2010-01-13 Polymun Scientific Immunbiologische Forschung GmbH Liposomale zusammensetzung einen wirkstoff zur relaxierung glatter muskulatur enthaltend, die herstellung dieser zusammensetzung und deren therapeutische verwendung
US20080213352A1 (en) * 2007-03-02 2008-09-04 Luna Innovations Incorporated Liposome carriers for in vivo delivery of fullerenes
DE102007036294A1 (de) 2007-07-31 2009-02-05 Gea Westfaliasurge Gmbh Vorrichtung und ein Verfahren zum Bereitstellen von Informationen über Tiere beim Durchlaufen eines Tierdurchganges
US9713591B2 (en) 2008-10-07 2017-07-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same
WO2010058840A1 (ja) * 2008-11-20 2010-05-27 テルモ株式会社 リポソームからの薬物放出手段および放出性評価法
US20100129430A1 (en) * 2008-11-24 2010-05-27 Stavroula Sofou Liposome drug carriers with ph-sensitivity
BR112013016365A2 (pt) * 2010-12-27 2018-06-26 Terumo Corp composição de lipossoma e processo para produção do mesmo
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586790B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
WO2014121235A2 (en) * 2013-02-01 2014-08-07 Zoneone Pharma, Inc. Transformation of drug cyclodextrin complex compositions into compositions of mixtures of lipid vesicle encapsulated drug and cyclodextrin drug complexes
WO2014121211A2 (en) * 2013-02-01 2014-08-07 Zoneone Pharma, Inc. Remote loading of sparingly water-soluble drugs into liposomes
WO2014153192A1 (en) * 2013-03-14 2014-09-25 Zoneone Pharma, Inc. Pharmaceutical formulations of chelating agents as a metal removal treatment system
CN106999419A (zh) 2014-08-04 2017-08-01 佐尼奥尼制药股份有限公司 远程装载略微水溶性药物至脂质膜泡
US11331272B2 (en) * 2017-01-18 2022-05-17 Temasek Life Sciences Laboratory Limited Hyperstabilized liposomes increase targeting of mitotic cells
JP2020111523A (ja) * 2019-01-09 2020-07-27 国立研究開発法人理化学研究所 機能性ナノ構造体
GB202200962D0 (en) * 2022-01-25 2022-03-09 Cytoseek Ltd Polymer additives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
US5972379A (en) * 1995-02-14 1999-10-26 Sequus Pharmaceuticals, Inc. Liposome composition and method for administering a quinolone
WO1996032930A1 (en) * 1995-04-18 1996-10-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition
IL140892A0 (en) * 1998-08-12 2002-02-10 Yissum Res Dev Co Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
DE60008234T2 (de) * 1999-04-29 2004-12-30 Alza Corp., Mountain View Liposomenzusammensetzungen zur verbesserten wirkstoffzurückhaltung

Similar Documents

Publication Publication Date Title
JP2005505602A5 (https=)
NO20042367L (no) Mikronisert filmdannende pulver omfattende et aktivt stoff
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
NO2017047I1 (no) Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
EP1698329A4 (en) PHARMACEUTICAL NANOTEILS, METHOD FOR THE PRODUCTION THEREOF AND PARENTERALLY APPLIED PRODUCT FROM NANOTEILES
PL378932A1 (pl) Zastosowanie ivermectiny do leczenia schorzeń dermatologicznych
HRP20030871A2 (en) Anthranilic acid amides, method for the production therefo, their use as antiarrhytmia agents, and pharmaceutical preparations thereof
HUE055056T2 (hu) 1,2,4-oxadiazol-benzoesav vegyület és alkalmazása nonszensz szupresszióra és betegség kezelésére
CA2481848A1 (en) Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation
ZA200507346B (en) Topical formulation of ivermectin for the treatment of dermatological conditions
WO2004047792A3 (de) Liposomale glucocorticoide
PL366855A1 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
WO2004071382A3 (en) Substituted heterocycles
WO2003032947A3 (en) A method for preparing liposome formulations with a predefined release profile
MX2007013623A (es) Preparacion externa para la piel.
ZA200510170B (en) Method of reducing the harmful effects of orally or transdermally delivered nicotine
WO2006068890A3 (en) Lipid particles comprising bioactive agents, methods of preparing and uses thereof
AU2003241915A1 (en) Vaporizer, various apparatuses including the same and method of vaporization
AU2003214683A1 (en) Manufacturing method of monoglyceride sulfonate, toilet soap composition using the same, and manufacturing method of toilet soap composition comprising salt
WO2002041831A3 (en) Inositol derivatives for increasing chloride secretion and inhibiting inflammation
DE50202227D1 (de) Arzneimittel enthaltend einen effektor des glutathionmetabolismus zusammen mit alpha-liponsäure im rahmen der nierenersatztherapie
WO2005123646A3 (en) Fluoroorganic compounds and anti-fouling treatments
AU2003266965A1 (en) Use of carboxamides for the treatment of tinnitus
WO2004041166A3 (en) Dosage forms containing stabilized choline and method for preparing same
WO2004071386A3 (en) Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use